Nuclear factor-κB: its role in health and disease
暂无分享,去创建一个
Bharat B. Aggarwal | B. Aggarwal | Ashok Kumar | Y. Takada | A. Boriek | Ashok Kumar | Yasunari Takada | Aladin M. Boriek
[1] Sujay K. Singh,et al. Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase. , 2003, The Journal of biological chemistry.
[2] T. Ogihara,et al. In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction , 1997, Nature Medicine.
[3] G. Courtois,et al. Mature T cells depend on signaling through the IKK complex. , 2003, Immunity.
[4] C. Kaltschmidt,et al. NF-kB: a crucial transcription factor for glial and neuronal cell function , 1997, Trends in Neurosciences.
[5] P. Barnes,et al. Inhaled glucocorticoids for asthma. , 1995, The New England journal of medicine.
[6] F. Autschbach,et al. Cell specific effects of glucocorticoid treatment on the NF-κBp65/IκBα system in patients with Crohn’s disease , 1999 .
[7] Jennifer Y. Zhang,et al. NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia , 2003, Nature.
[8] E. Ho,et al. Antioxidants, NFκB Activation, and Diabetogenesis , 1999 .
[9] B. Aggarwal,et al. Nuclear Transcription Factor-kappaB in Hodgkin's Disease , 2003, Leukemia & lymphoma.
[10] M. Wainberg,et al. Inducible Expression of IκBα Repressor Mutants Interferes with NF-κB Activity and HIV-1 Replication in Jurkat T Cells* , 1998, The Journal of Biological Chemistry.
[11] Inder M. Verma,et al. Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene , 1999 .
[12] T. Lawrence,et al. Possible new role for NF-κB in the resolution of inflammation , 2001, Nature Medicine.
[13] G. Hansson,et al. Nuclear factor kappa-B and the heart. , 2001, Journal of the American College of Cardiology.
[14] David Baltimore,et al. Multiple nuclear factors interact with the immunoglobulin enhancer sequences , 1986, Cell.
[15] Ashok Kumar,et al. Mechanical stress activates the nuclear factor‐kappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[16] K. Wilkinson. Signal transduction: Aspirin, ubiquitin and cancer , 2003, Nature.
[17] J. Tidball,et al. Do immune cells promote the pathology of dystrophin-deficient myopathies? , 2001, Neuromuscular Disorders.
[18] R. Gaynor,et al. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. , 2001, The Journal of clinical investigation.
[19] A. Baldwin,et al. NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[20] G. Nabel,et al. An inducible transcription factor activates expression of human immunodeficiency virus in T cells , 1990, Nature.
[21] D. Wallach,et al. MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1 , 1997, Nature.
[22] Zhaodan Cao,et al. NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176 , 1998 .
[23] Kozo Nakamura,et al. A novel therapeutic vaccine approach, targeting RANKL, prevents bone destruction in bone-related disorders , 2002, Journal of Bone and Mineral Metabolism.
[24] M. Mattson,et al. NF-kappaB in neuronal plasticity and neurodegenerative disorders. , 2001, The Journal of clinical investigation.
[25] David Baltimore,et al. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses , 1995, Cell.
[26] F. Weih,et al. Essential Role of RelB in Germinal Center and Marginal Zone Formation and Proper Expression of Homing Chemokines1 , 2001, The Journal of Immunology.
[27] K. Miyazawa,et al. Constitutive transcription of the human interleukin-6 gene by rheumatoid synoviocytes: spontaneous activation of NF-kappaB and CBF1. , 1998, The American journal of pathology.
[28] P. Baeuerle,et al. NF-kappa B activation in human knee-joint synovial tissue during the early stage of joint inflammation. , 1997, Biochemical Society transactions.
[29] M. Wainberg,et al. Inducible expression of IkappaBalpha repressor mutants interferes with NF-kappaB activity and HIV-1 replication in Jurkat T cells. , 1998, The Journal of biological chemistry.
[30] P. Herrlich,et al. Sequential DNA damage‐independent and ‐dependent activation of NF‐κB by UV , 1998 .
[31] A. D'amico,et al. RelB Is Essential for the Development of Myeloid-Related CD8α− Dendritic Cells but Not of Lymphoid-Related CD8α+ Dendritic Cells , 1998 .
[32] M. Cybulsky,et al. NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? , 2001, The Journal of clinical investigation.
[33] R. Chaganti,et al. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50 , 1991, Cell.
[34] S. Akira,et al. Brief Definitive Report Essential Role of Nuclear Factor (nf)- B–inducing Kinase and Inhibitor of B (i B) Kinase ␣ in Nf- B Activation through Lymphotoxin  Receptor, but Not through Tumor Necrosis Factor Receptor I , 2022 .
[35] D. Nelson,et al. NF-kappaB signaling and human disease. , 2001, Current opinion in genetics & development.
[36] D. Donnai,et al. Incontinentia pigmenti (Bloch-Sulzberger syndrome). , 1993, Journal of medical genetics.
[37] A. Hida,et al. Importance of NF-κB in rheumatoid synovial tissues: in situ NF-κB expression and in vitro study using cultured synovial cells , 2001 .
[38] I. Verma,et al. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. , 1999, Science.
[39] Michael Karin,et al. NF-kappaB at the crossroads of life and death. , 2002, Nature immunology.
[40] P. Elliott,et al. Proteasome Inhibition: a New Strategy in Cancer Treatment , 2000, Investigational New Drugs.
[41] Jennifer Y. Zhang,et al. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. , 2003, Nature.
[42] H. Kwon,et al. Hostile takeovers: viral appropriation of the NF-kappaB pathway. , 2001, The Journal of clinical investigation.
[43] A. Hoffmann,et al. CK2 Is a C-Terminal IkappaB Kinase Responsible for NF-kappaB Activation during the UV Response. , 2003, Molecular cell.
[44] Y. Ahn,et al. A20 Is Dynamically Regulated in the Heart and Inhibits the Hypertrophic Response , 2003, Circulation.
[45] F. Weih,et al. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family , 1995, Cell.
[46] David Baltimore,et al. Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism , 1986, Cell.
[47] S. Johnston,et al. Rhinovirus Infection Induces Expression of Its Own Receptor Intercellular Adhesion Molecule 1 (ICAM-1) via Increased NF-κB-mediated Transcription* , 1999, The Journal of Biological Chemistry.
[48] G. Bonizzi,et al. Mechanisms of Persistent NF-κB Activity in the Bronchi of an Animal Model of Asthma1 , 2000, The Journal of Immunology.
[49] C. Bever,et al. Induction of RANTES chemokine expression in human astrocytic cells is dependent upon activation of NF-kappaB transcription factor. , 2001, International journal of molecular medicine.
[50] G. Vita,et al. Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy. , 2003, Neurology.
[51] J. Beckmann,et al. Pathophysiology of limb girdle muscular dystrophy type 2A: hypothesis and new insights into the IκBα/NF-κB survival pathway in skeletal muscle , 2001, Journal of Molecular Medicine.
[52] Burkhard Haefner,et al. NF-κB: arresting a major culprit in cancer , 2002 .
[53] R. Hay,et al. Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα , 1999, Oncogene.
[54] C. Hunter,et al. NF-κB Family of Transcription Factors: Central Regulators of Innate and Adaptive Immune Functions , 2002, Clinical Microbiology Reviews.
[55] I. Adcock,et al. Inducible nitric oxide synthase after sensitization and allergen challenge of Brown Norway rat lung , 1997, British journal of pharmacology.
[56] P. Khavari,et al. Divergent gene regulation and growth effects by NF-κB in epithelial and mesenchymal cells of human skin , 2003, Oncogene.
[57] E. Zandi,et al. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. , 1997, Nature.
[58] T. Maniatis,et al. NF-(cid:1) B signaling pathways in mammalian and insect innate immunity , 2001 .
[59] Chris Albanese,et al. NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1 , 1999, Molecular and Cellular Biology.
[60] A. Lin,et al. Activation of NF-κB is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[61] Hector R. Wong,et al. Nuclear factor-κB as a therapeutic target in critical care medicine , 2003 .
[62] T. Rando,et al. NF kappa B and AP-1 mediate transcriptional responses to oxidative stress in skeletal muscle cells. , 2001, Free radical biology & medicine.
[63] M. Karin,et al. The IKK/NF-kappaB pathway. , 2002, Critical care medicine.
[64] M. Cybulsky,et al. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. , 1999, Circulation research.
[65] D. Baltimore,et al. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. , 1995, Nature.
[66] I. Adcock,et al. Effects of inhaled β agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma , 1999, Thorax.
[67] C. Kaltschmidt,et al. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. , 1997, Trends in neurosciences.
[68] Michael Karin,et al. NF-κB at the crossroads of life and death , 2002, Nature Immunology.
[69] W. Sha,et al. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha. , 1999, Immunity.
[70] M. Mcdaniel,et al. Interleukin-1 beta-induced nitric oxide synthase expression by rat pancreatic beta-cells: evidence for the involvement of nuclear factor kappa B in the signaling mechanism. , 1995, Endocrinology.
[71] T. Serikawa,et al. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase. , 1999, Nature genetics.
[72] B. Aggarwal,et al. Site-specific tyrosine phosphorylation of IkappaBalpha negatively regulates its inducible phosphorylation and degradation. , 1996, The Journal of biological chemistry.
[73] D. Baltimore,et al. B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. , 1996, Journal of immunology.
[74] M. Karin,et al. Is NF-kappaB the sensor of oxidative stress? , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[75] T. Maniatis,et al. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. , 1996, Cell.
[76] C. Mueller-Dieckmann,et al. Tyrosine Phosphorylation of IκB-α Activates NF-κB without Proteolytic Degradation of IκB-α , 1996, Cell.
[77] I. Rodger,et al. Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure. , 1998, Circulation.
[78] C. Nguyên,et al. A Small Molecule Inhibitor of Redox-Regulated NF-κB and Activator Protein-1 Transcription Blocks Allergic Airway Inflammation in a Mouse Asthma Model1 , 2002, The Journal of Immunology.
[79] J. D. Porter,et al. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. , 2002, Human molecular genetics.
[80] H. Kwon,et al. Hostile takeovers: viral appropriation of the NF-kB pathway , 2001 .
[81] M. Mattson,et al. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[82] Michael Karin,et al. Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ , 2001, Science.
[83] B. Aggarwal. Signalling pathways of the TNF superfamily: a double-edged sword , 2003, Nature Reviews Immunology.
[84] B. Aggarwal,et al. Site-specific Tyrosine Phosphorylation of IκBα Negatively Regulates Its Inducible Phosphorylation and Degradation* , 1996, The Journal of Biological Chemistry.
[85] Yasushi Matsumura,et al. Involvement of Nuclear Factor-&kgr;B and Apoptosis Signal-Regulating Kinase 1 in G-Protein–Coupled Receptor Agonist–Induced Cardiomyocyte Hypertrophy , 2002, Circulation.
[86] J. Engelhardt,et al. Tyrosine phosphorylation of I kappa B alpha activates NF kappa B through a redox-regulated and c-Src-dependent mechanism following hypoxia/reoxygenation. , 2003, The Journal of biological chemistry.
[87] C. Irvin,et al. Rapid activation of nuclear factor-kappaB in airway epithelium in a murine model of allergic airway inflammation. , 2002, The American journal of pathology.
[88] P. Herrlich,et al. Sequential DNA damage-independent and -dependent activation of NF-kappaB by UV. , 1998, The EMBO journal.
[89] G. A. Limb,et al. Activation of nuclear factor kappa B in Crohn's disease , 1998, Inflammation Research.
[90] E. Schmidt,et al. IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. , 2001, Cell.
[91] S. Klauck,et al. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. , 2000, Nature.
[92] T. Bauer. Particles and periimplant bone resorption. , 2002, Clinical orthopaedics and related research.
[93] Céline Gélinas,et al. Rel/NF‐κB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors , 1999, The EMBO journal.
[94] L. Cro,et al. Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies. , 1993, Oncogene.
[95] A. Leonardi,et al. Requirement for NF-kappaB in osteoclast and B-cell development. , 1997, Genes & development.
[96] R. Gaynor,et al. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β , 1998, Nature.
[97] Lu Zhou,et al. NFκB and AP-1 mediate transcriptional responses to oxidative stress in skeletal muscle cells , 2001 .
[98] Richard T. Lee,et al. Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. , 2004, The Journal of clinical investigation.
[99] J. Christman,et al. The role of nuclear factor-kappa B in pulmonary diseases. , 2000, Chest.
[100] M. Karin,et al. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. , 2001, Science.
[101] C. Snapper,et al. Nuclear Factor (NF)-κB2 (p100/p52) Is Required for Normal Splenic Microarchitecture and B Cell–mediated Immune Responses , 1998, The Journal of experimental medicine.
[102] J. Cusack,et al. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB , 1999, Nature Medicine.
[103] T. Mak,et al. Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. , 2000, Genes & development.
[104] Ulrich Siebenlist,et al. Requirement for NF-κB in osteoclast and B-cell development , 1997 .
[105] J. Molkentin,et al. Is nuclear factor kappaB an attractive therapeutic target for treating cardiac hypertrophy? , 2003, Circulation.
[106] A. Lin,et al. Activation of nuclear factor- B is necessary for myotrophin-induced cardiac hypertrophy , 2002 .
[107] Michael Karin,et al. Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway , 2001, Science.
[108] S. Gerondakis,et al. Rel/NF‐κB transcription factors: key mediators of B‐cell activation , 2000 .
[109] J. Beckmann,et al. Loss of Calpain 3 Proteolytic Activity Leads to Muscular Dystrophy and to Apoptosis-Associated Iκbα/Nuclear Factor κb Pathway Perturbation in Mice , 2000, The Journal of cell biology.
[110] J. Hoidal,et al. NADPH oxidase promotes NF-kappaB activation and proliferation in human airway smooth muscle. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[111] R. Gaynor,et al. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. , 1998, Nature.
[112] A. Smahi,et al. The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. , 2002, Human molecular genetics.
[113] M. Neurath,et al. Local administration of antisense phosphorothiate olignucleotides to the p65 subunit of NF–κB abrogates established experimental colitis in mice , 1996, Nature Medicine.
[114] Joseph A. DiDonato,et al. Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis , 1995, Science.
[115] R. Chaganti,et al. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50. , 1991, Cell.
[116] J. Beckmann,et al. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A. , 1999, Nature medicine.
[117] Michael Karin,et al. The Beginning of the End: IκB Kinase (IKK) and NF-κB Activation* , 1999, The Journal of Biological Chemistry.
[118] Nanxin Li,et al. Oxidative stress and gene expression: The AP‐1 and NF‐κB connections , 2001 .
[119] M. Karin,et al. IKKbeta is essential for protecting T cells from TNFalpha-induced apoptosis. , 2001, Immunity.
[120] D. Goeddel,et al. NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[121] J. Prehn,et al. Activation of Nuclear Factor κb and bcl-x Survival Gene Expression by Nerve Growth Factor Requires Tyrosine Phosphorylation of IκBα , 2001, The Journal of cell biology.
[122] F. Autschbach,et al. Cell specific effects of glucocorticoid treatment on the NF-kappaBp65/IkappaBalpha system in patients with Crohn's disease. , 1999, Gut.
[123] S. Akira,et al. Limb and skin abnormalities in mice lacking IKKalpha. , 1999, Science.
[124] E. Zandi,et al. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. , 1997, Cell.
[125] G. Moretto,et al. Activation of NF-kappaB and c-jun transcription factors in multiple sclerosis lesions. Implications for oligodendrocyte pathology. , 1999, The American journal of pathology.
[126] J. Christman,et al. Impact of Basic Research on Tomorrow's MedicineThe Role of Nuclear Factor-κ B in Pulmonary Diseases , 2000 .
[127] Inder M Verma,et al. NF-kappaB regulation in the immune system. , 2002, Nature reviews. Immunology.
[128] Y. Abu-Amer,et al. NF-κB and bone: The breaking point , 1997, Nature Medicine.
[129] M. Cybulsky,et al. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.
[130] D. Baltimore,et al. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986. 46: 705-716. , 2006, Journal of immunology.
[131] P. Ricciardi-Castagnoli,et al. Brief Definitive Report Dendritic Cell Survival and Maturation Are Regulated by Different Signaling Pathways , 2022 .
[132] J. Newcombe,et al. Transcription factor NF-kappaB and inhibitor I kappaBalpha are localized in macrophages in active multiple sclerosis lesions. , 1998, Journal of neuropathology and experimental neurology.
[133] B. Volk,et al. Inhibition of NF-kB potentiates amyloid b-mediated neuronal apoptosis (IkB-aytumor necrosis factoryoxidative stressyneuroprotectionypreconditioning) , 1999 .
[134] E. Schmidt,et al. IKKα Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland Development , 2001, Cell.
[135] G. Courtois,et al. Complementation Cloning of NEMO, a Component of the IκB Kinase Complex Essential for NF-κB Activation , 1998, Cell.
[136] Sergei S Makarov,et al. NF-kappaB in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction , 2001, Arthritis research.
[137] D. Carrasco,et al. The v‐rel oncogene promotes malignant T‐cell leukemia/lymphoma in transgenic mice. , 1996, The EMBO journal.
[138] M. Feldmann,et al. Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[139] I. Adcock,et al. Transcription factors and asthma. , 1998, The European respiratory journal.
[140] J. Schaper,et al. Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure. , 1997, European heart journal.
[141] P. Khavari,et al. Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[142] S. Gerondakis,et al. The regulation and roles of Rel/NF-kappa B transcription factors during lymphocyte activation. , 1998, Current opinion in immunology.
[143] David M. Rothwarf,et al. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB , 1997, Nature.
[144] P. Keng,et al. Expression of Either NF‐κB p50 or p52 in Osteoclast Precursors Is Required for IL‐1‐Induced Bone Resorption , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[145] C. Mueller-Dieckmann,et al. Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha. , 1996, Cell.
[146] P. Khavari,et al. Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB , 1998 .
[147] Burkhard Haefner,et al. NF-kappa B: arresting a major culprit in cancer. , 2002, Drug discovery today.
[148] I. Adcock,et al. Effects of inhaled corticosteroid therapy on expression and DNA-binding activity of nuclear factor kappaB in asthma. , 2000, American journal of respiratory and critical care medicine.
[149] N. Paran,et al. Activation of NF-κB by hepatitis B virus X protein through an IκB kinase-independent mechanism , 2001 .
[150] M J May,et al. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.
[151] A. Hoffmann,et al. CK2 Is a C-Terminal IκB Kinase Responsible for NF-κB Activation during the UV Response , 2003 .
[152] I. Adcock,et al. Ozone induction of cytokine‐induced neutrophil chemoattractant (CINC) and nuclear factor‐κb in rat lung: inhibition by corticosteroids , 1996, FEBS letters.
[153] B. Aggarwal,et al. Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates. , 1998, The Journal of biological chemistry.
[154] Nanxin Li,et al. Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[155] Michael Karin,et al. Is NF‐κB the sensor of oxidative stress? , 1999 .
[156] T. Maniatis,et al. Site-Specific Phosphorylation of IκBα by a Novel Ubiquitination-Dependent Protein Kinase Activity , 1996, Cell.
[157] G. Freeman,et al. Induction of nuclear factor κB and activation protein 1 in postischemic myocardium , 1997, FEBS letters.
[158] M. Stacey,et al. The allergen Der p1 induces NF-kappaB activation through interference with IkappaB alpha function in asthmatic bronchial epithelial cells. , 1997, Biochemical and biophysical research communications.
[159] D. Baltimore,et al. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. , 1986, Cell.
[160] K. Selmaj,et al. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro , 1988, Annals of neurology.
[161] C. Angermann,et al. Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure. , 2003, Cardiovascular research.
[162] M. Okabe,et al. Involvement of distinct cellular compartments in the abnormal lymphoid organogenesis in lymphotoxin-alpha-deficient mice and alymphoplasia (aly) mice defined by the chimeric analysis. , 1999, Journal of immunology.
[163] B. Hilliard,et al. Transcriptional Regulation of Type I Diabetes by NF-κB 1 , 2003, The Journal of Immunology.
[164] Wei-Ping Qian,et al. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor κB ligand and tumor necrosis factor α from T cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[165] D. Holmes,et al. Activated nuclear factor-kappaB is present in the coronary vasculature in experimental hypercholesterolemia. , 2000, Atherosclerosis.
[166] D. Eizirik,et al. Inhibition of cytokine-induced NF-kappaB activation by adenovirus-mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis. , 2001, Diabetes.
[167] J. Beckmann,et al. Pathophysiology of limb girdle muscular dystrophy type 2A: hypothesis and new insights into the IkappaBalpha/NF-kappaB survival pathway in skeletal muscle. , 2001, Journal of molecular medicine.
[168] M. Karin,et al. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. , 2000, Seminars in immunology.
[169] T. Deerinck,et al. The IKKβ Subunit of IκB Kinase (IKK) is Essential for Nuclear Factor κB Activation and Prevention of Apoptosis , 1999, The Journal of experimental medicine.
[170] M. Karin,et al. The IKK/NF-kappa B pathway. , 2002 .
[171] Sujay K. Singh,et al. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. , 2003, Blood.
[172] Shokei Kim,et al. Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats. , 1998, Cardiovascular research.
[173] A. Strasser,et al. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. , 1995, Genes & development.
[174] Xianglin Shi,et al. New Insights into the Role of Nuclear Factor-κB in Cell Growth Regulation , 2001 .
[175] Lung-Chi Chen,et al. Ozone-induced IL-8 expression and transcription factor binding in respiratory epithelial cells. , 1997, The American journal of physiology.
[176] E. Oltz,et al. An intact NF-κB signaling pathway is required for maintenance of mature B cell subsets , 1999 .
[177] R. Knuechel,et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. , 1996, The Journal of clinical investigation.
[178] J. Tidball,et al. Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle. , 2001, Clinical immunology.
[179] D. White,et al. Rel/NF-kappaB/IkappaB proteins and cancer. , 1996, Oncogene.
[180] E. Ho,et al. Antioxidants, NFkappaB activation, and diabetogenesis. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[181] I. Adcock,et al. Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. , 1998, American journal of respiratory and critical care medicine.
[182] A. Sica,et al. Interaction of NF-κB and NFAT with the Interferon-γ Promoter* , 1997, The Journal of Biological Chemistry.
[183] N. Tarantino,et al. In Vivo Inhibition of NF-κB in T-Lineage Cells Leads to a Dramatic Decrease in Cell Proliferation and Cytokine Production and to Increased Cell Apoptosis in Response to Mitogenic Stimuli, But Not to Abnormal Thymopoiesis , 1999, The Journal of Immunology.
[184] 細田 昌良. Effects of rhinovirus infection on histamine and cytokine production by cell lines from human mast cells and basophils , 2003 .
[185] Y. Ben-Neriah. Regulatory functions of ubiquitination in the immune system , 2002, Nature Immunology.
[186] P. Baeuerle,et al. Role of nuclear factor‐kappa B in atherogenesis , 1997, Experimental physiology.
[187] J. Tidball,et al. Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity. , 1997, The Journal of clinical investigation.
[188] G. Courtois,et al. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. , 1998, Cell.
[189] P. Baeuerle,et al. Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. , 1996, Arthritis and rheumatism.
[190] B. Aggarwal,et al. Nuclear factor-kappa B and cancer: its role in prevention and therapy. , 2002, Biochemical pharmacology.
[191] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[192] D. Corry,et al. Mechanical stretch activates nuclear factor‐kappaB, activator protein‐1, and mitogen‐activated protein kinases in lung parenchyma: implications in asthma , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[193] Claus Scheidereit,et al. NF-κB Function in Growth Control: Regulation of Cyclin D1 Expression and G0/G1-to-S-Phase Transition , 1999, Molecular and Cellular Biology.
[194] B. Aggarwal,et al. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines , 2001, Oncogene.
[195] Swaroop Aradhya,et al. NF-κB signaling and human disease , 2001 .
[196] Stuart A. Lipton,et al. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades , 2001, Nature.
[197] Mark P. Mattson,et al. NF-κB in neuronal plasticity and neurodegenerative disorders , 2001 .
[198] A. Hida,et al. Importance of NF-kappaB in rheumatoid synovial tissues: in situ NF-kappaB expression and in vitro study using cultured synovial cells. , 2001, Annals of the rheumatic diseases.
[199] R. Surabhi,et al. RNA Interference Directed against Viral and Cellular Targets Inhibits Human Immunodeficiency Virus Type 1 Replication , 2002, Journal of Virology.
[200] E. Zandi,et al. IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. , 1998, Nature.
[201] E. Hirsch,et al. Nuclear translocation of NF‐κB in cholinergic neurons of patients with Alzheimer's disease , 1997, Neuroreport.
[202] M. Boothby,et al. Perturbation of the T Lymphocyte Lineage In Transgenic Mice Expressing a Constitutive Repressor of Nuclear Factor (NF)-κB , 1997, The Journal of experimental medicine.
[203] S. Klauck,et al. Genomic rearrangement in NEMO impairs NF-κB activation and is a cause of incontinentia pigmenti , 2000, Nature.
[204] B. Rayet,et al. Aberrant rel/nfkb genes and activity in human cancer , 1999, Oncogene.
[205] J. Inoue,et al. Induction of interleukin‐12 p40 transcript by CD40 ligation via activation of nuclear factor‐xB , 1997, European journal of immunology.
[206] S. Johnston,et al. Respiratory Epithelial Cell Expression of Vascular Cell Adhesion Molecule-1 and Its Up-regulation by Rhinovirus Infection via NF-κB and GATA Transcription Factors* , 1999, The Journal of Biological Chemistry.
[207] F. Chen,et al. New insights into the role of nuclear factor-kappaB in cell growth regulation. , 2001, The American journal of pathology.
[208] R. Coffey,et al. Her-2/neu overexpression induces NF-κB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IκB-α that can be inhibited by the tumor suppressor PTEN , 2001, Oncogene.
[209] K. Nicholson,et al. Respiratory viruses and exacerbations of asthma in adults. , 1993, BMJ.
[210] V. Godfrey,et al. Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. , 2000, Molecular cell.
[211] Sujay K. Singh,et al. Hydrogen Peroxide Activates NF-κB through Tyrosine Phosphorylation of IκBα and Serine Phosphorylation of p65 , 2003, Journal of Biological Chemistry.
[212] L. Ährlund‐Richter,et al. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling. , 1999, Cancer research.
[213] J. Egido,et al. Simvastatin reduces NF-kappaB activity in peripheral mononuclear and in plaque cells of rabbit atheroma more markedly than lipid lowering diet. , 2003, Cardiovascular research.
[214] T. Deerinck,et al. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. , 1999, Science.
[215] E. Oltz,et al. An intact NF-kappa B signaling pathway is required for maintenance of mature B cell subsets. , 1999, Molecular immunology.
[216] A. D'amico,et al. RelB is essential for the development of myeloid-related CD8alpha- dendritic cells but not of lymphoid-related CD8alpha+ dendritic cells. , 1998, Immunity.
[217] G. Bonizzi,et al. Correlation between nuclear factor-kappaB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma. , 2000, American journal of respiratory and critical care medicine.
[218] D. Lo,et al. Expression of relB is required for the development of thymic medulla and dendritic cells , 1995, Nature.
[219] Michael Karin,et al. The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalling , 2000 .
[220] Wei-Ping Qian,et al. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[221] K. Jeang,et al. Potent and Stable Attenuation of Live-HIV-1 by Gain of a Proteolysis-resistant Inhibitor of NF-κB (IκB-αS32/36A) and the Implications for Vaccine Development* , 1999, The Journal of Biological Chemistry.
[222] Sujay K. Singh,et al. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis , 2003 .
[223] H. Pahl,et al. Activators and target genes of Rel/NF-kappaB transcription factors. , 1999, Oncogene.
[224] Y. Obata,et al. NF-κB RelA-deficient Lymphocytes: Normal Development of T Cells and B Cells, Impaired Production of IgA and IgG1 and Reduced Proliferative Responses , 1997, The Journal of experimental medicine.
[225] M. Boothby,et al. NF-κB/Rel Participation in the Lymphokine-Dependent Proliferation of T Lymphoid Cells1 , 2001, The Journal of Immunology.
[226] S. Manna,et al. Pervanadate-induced Nuclear Factor-κB Activation Requires Tyrosine Phosphorylation and Degradation of IκBα , 2000, The Journal of Biological Chemistry.
[227] E. Ho,et al. Supplementation of N‐acetylcysteine inhibits NFκB activation and protects against alloxan‐induced diabetes in CD‐1 mice , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[228] D. Levy,et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.
[229] C. Snapper,et al. Multiple Hemopoietic Defects and Lymphoid Hyperplasia in Mice Lacking the Transcriptional Activation Domain of the c-Rel Protein , 1998, The Journal of experimental medicine.
[230] M. Cybulsky,et al. NF-κB: pivotal mediator or innocent bystander in atherogenesis? , 2001 .
[231] M. Karin,et al. IKKβ Is Essential for Protecting T Cells from TNFα-Induced Apoptosis , 2001 .
[232] C. Tato,et al. Identification of a Role for NF-κB2 in the Regulation of Apoptosis and in Maintenance of T Cell-Mediated Immunity to Toxoplasma gondii1 , 2000, The Journal of Immunology.
[233] T. Lawrence,et al. Possible new role for NF-kappaB in the resolution of inflammation. , 2001, Nature medicine.
[234] T. Maniatis,et al. MEKK1 activates both IkappaB kinase alpha and IkappaB kinase beta. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[235] G. Kollias,et al. Tumor necrosis factor‐α/nuclear transcription factor‐κB signaling in periprosthetic osteolysis , 2000 .
[236] E. Zandi,et al. The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB Activation , 1997, Cell.
[237] G. Vita,et al. Activation of nuclear factor-κB in inflammatory myopathies and Duchenne muscular dystrophy , 2003, Neurology.
[238] A. Sica,et al. Interaction of NF-kappaB and NFAT with the interferon-gamma promoter. , 1997, The Journal of biological chemistry.
[239] I. Charo,et al. Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.
[240] M. Stacey,et al. The Allergen Der p1 Induces NF-kB Activation through Interference with IkBα Function in Asthmatic Bronchial Epithelial Cells , 1997 .
[241] Y. Abu-Amer,et al. NF-kappaB and bone: the breaking point. , 1997, Nature medicine.
[242] T. Deerinck,et al. Abnormal Morphogenesis But Intact IKK Activation in Mice Lacking the IKKα Subunit of IκB Kinase , 1999 .
[243] B. Mitchell. The proteasome--an emerging therapeutic target in cancer. , 2003, The New England journal of medicine.
[244] B. Aggarwal,et al. Antiproliferative Effects of IFN-α Correlate with the Downregulation of Nuclear Factor-κB in Human Burkitt Lymphoma Daudi Cells , 2001 .
[245] S. Manna,et al. Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IkappaBalpha. Comparison with tumor necrosis factor-alpha. , 2000, The Journal of biological chemistry.
[246] E. Zandi,et al. IKK-γ is an essential regulatory subunit of the IκB kinase complex , 1998, Nature.
[247] J. D. Porter,et al. Dissection of temporal gene expression signatures of affected and spared muscle groups in dystrophin-deficient (mdx) mice. , 2003, Human molecular genetics.